KDP34

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

KDP34 is a dodecapeptide with the sequence DFQTWSFLYVEN or Asp-Phe-Gln-Thr-Trp-Ser-Phe-Leu-Tyr-Val-Glu-Asn. It is a knuckle epitope peptide that is a modified fragment of bone morphogenetic protein 2 (BMP-2), with similar effects and higher potency. Recombinant BMP-2 is used clinically to enhance healing of bones, such as in bone transplants or bone grafts, but needs to be used very carefully due to side effects such as inflammation and inappropriate bone growth in non targeted tissues. Modified peptide analogues of BMP-2 such as KDP34 have been developed as potential alternatives which may show more selectivity and an improved side effect profile.

KDP34 is a dodecapeptide with the sequence DFQTWSFLYVEN or Asp-Phe-Gln-Thr-Trp-Ser-Phe-Leu-Tyr-Val-Glu-Asn. It is a knuckle epitope peptide that is a modified fragment of bone morphogenetic protein 2 (BMP-2), with similar effects and higher potency. Recombinant BMP-2 is used clinically to enhance healing of bones, such as in bone transplants or bone grafts, but needs to be used very carefully due to side effects such as inflammation and inappropriate bone growth in non targeted tissues. Modified peptide analogues of BMP-2 such as KDP34 have been developed as potential alternatives which may show more selectivity and an improved side effect profile.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1340685014 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.